Gesellschaftsrecht / M&A

Prozesse

Finanzmarktrecht

Arbeitsrecht und Vergütung für Führungskräfte

Steuern

Homburger News

Homburger and Shareholders of MIV Asset Management AG

On December 2, 2024, Bank J. Safra Sarasin AG announced the acquisition of 100% of the shares of MIV Asset Management AG («MIV»).
MIV is characterized through its investments in medical technology and its flagship fund, the MIV Global Medtech Fund. MIV is known for its innovative approach and in-depth knowledge of the sector. MIV&#8217;s offering is an addition to Bank J. Safra Sarasin&#8217;s range of thematic equity strategies, which are available to both private and institutional investors.
MIV&#8217;s investment strategy and organizational structure will remain unchanged to ensure solid performance and seamless client service.
The Homburger team advising the selling shareholders was led by Daniel Hasler and Daniel Daeniker and included Stefan Blunschi, Caspar Wehrle, Bianca Nedwed and Felix Beltle (all Corporate / M&amp;A), Marc Bircher (Litigation), Jürg Frick and Philipp Klein (both Financial Market Regulation), Stefan Oesterhelt, Peter Müller and Philipp Stiegeler (all Tax) as well as Jeremy Reichlin (Employment and Executive Compensation).

Homburger advised the shareholders of MIV Asset Management AG on the sale of 100% of their shares to Bank J. Safra Sarasin AG  

Kapitalmarkt

ADC Therapeutics

Homburger and ADC Therapeutics

On May 8, 2024, ADC Therapeutics SA (NYSE:ADCT), a commercial-stage biotechnology company headquartered in Switzerland, announced the offering of 13.4 m common shares and, to certain investors who so choose in lieu of common shares, pre-funded warrants to purchase 8.1 m common shares, raising aggregate gross proceeds of USD 105 m.
Homburger advised ADC Therapeutics SA on the Swiss law and tax aspects of this transaction. The Homburger team was led by Daniel Häusermann (Capital Markets, Corporate / M&amp;A) and included Estelle Piccard and Bianca Nedwed (both Capital Markets, Corporate / M&amp;A) as well as Stefan Oesterhelt and Philippe Weber (both Tax).

Homburger advised ADC Therapeutics SA on its USD 105 m Underwritten Offering of Common Shares and Pre-Funded Warrants

IP / IT

Wettbewerb

Regulierung

Cadence-webnews

Candence Design Systems Inc. aquires BETA CAE Systems

Homburger advises Cadence on its  USD 1.24 bn acquisition of BETA CAE Systems

On March 5, 2024, Cadence Design Systems Inc. (Nasdaq: CDNS), a leading global EDA and Intelligent System Design provider, announced that it has signed a definitive agreement to acquire BETA CAE Systems International AG, a leading provider of multi-domain, engineering simulation solutions headquartered in Switzerland.
Under the terms of the definitive agreement, Cadence will pay approximately USD 1.24 bn for the transaction, with 60 percent of the consideration to be paid in cash and 40 percent to be paid through the issuance of Cadence common stock to current BETA CAE shareholders. The transaction, which is subject to customary conditions, is expected to close in the second quarter of this year.
Homburger advises Cadence Design Systems Inc. on the Swiss aspects of the transaction. The Homburger team is led by Daniel Hasler and includes Léonard Aeschlimann, Bianca Nedwed, Daniel Bötticher, Paula Delissen and Luc Huber (all Corporate / M&amp;A), Gregor Bühler and Kimberly Amrein (both Employment and Executive Compensation), Kirsten Wesiak-Schmidt and Marc Wang (both IP / IT), Jonas Krull (Competition, Regulatory), as well as Peter Müller (Tax).

Bianca
Nedwed

Homburger advised the shareholders of MIV Asset Management AG on the sale of 100% of their shares to Bank J. Safra Sarasin AG

Homburger advised ADC Therapeutics SA on its USD 105 m Underwritten Offering of Common Shares and Pre-Funded Warrants

Homburger advises Cadence on its USD 1.24 bn acquisition of BETA CAE Systems

Join the Team

Bianca Nedwed

Karriere

Sprachen

Zulassung

Teams

BiancaNedwed

Homburger advised the shareholders of MIV Asset Management AG on the sale of 100% of their shares to Bank J. Safra Sarasin AG

Homburger advised ADC Therapeutics SA on its USD 105 m Underwritten Offering of Common Shares and Pre-Funded Warrants

Homburger advises Cadence on its USD 1.24 bn acquisition of BETA CAE Systems

Join the Team

Bianca Nedwed

Karriere

Sprachen

Zulassung

Teams

Bianca
Nedwed